CAPTRUST Financial Advisors
CLBT icon

CAPTRUST Financial Advisors’s Cellebrite CLBT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Sell
10,845
-28,479
-72% -$376K ﹤0.01% 2947
2026
Q1 		$542K Buy
+39,324
New +$593K ﹤0.01% 1982

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

CAPTRUST Financial Advisors's CLBT Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its Cellebrite (CLBT) stake by 72% in Q2 2026, selling an estimated $376K and leaving 10,845 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #2947.

CAPTRUST Financial Advisors first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. The position peaked at $542K in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • CAPTRUST Financial Advisors held 10,845 shares of Cellebrite worth $158K as of Q2 2026.
  • CAPTRUST Financial Advisors sold 28,479 Cellebrite shares in Q2 2026, an estimated $376K.
  • Cellebrite made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2947 holding.
  • CAPTRUST Financial Advisors first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
  • CAPTRUST Financial Advisors's Cellebrite position peaked at $542K in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.